C-reactive protein is essential for innate resistance to pneumococcal infection

Immunology

Volumn 142, Issue 3, 2014, Pages 414-420

  Paul Simons, J ^a   Loeffler, Jutta M ^a   Al Shawi, Raya ^a   Ellmerich, Stephan ^a   Hutchinson, Winston L ^a   Tennent, Glenys A ^a   Petrie, Aviva ^b   Raynes, John G ^c   de Souza, J Brian ^c   Lawrence, Rachel A ^d   Read, Kevin D ^e   Pepys, Mark B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Anti nuclear antibodies; C reactive protein; Host resistance; Mouse knockout; Pneumococcal infection

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HOST RESISTANCE; INNATE IMMUNITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION;

ANTI-NUCLEAR ANTIBODIES; C-REACTIVE PROTEIN; HOST RESISTANCE; MOUSE KNOCKOUT; PNEUMOCOCCAL INFECTION;

ANIMALS; C-REACTIVE PROTEIN; HUMANS; IMMUNITY, INNATE; MICE; MICE, KNOCKOUT; PHENOTYPE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84901979435     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12266     Document Type: Article

References (29)

1. Volanakis JE, Kaplan MH. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med 1971; 136:612-4.
2. Mold C, Nakayama S, Holzer TJ, Gewurz H, Du Clos TW. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J Exp Med 1981; 154:1703-8.
3. Yother J, Volanakis JE, Briles DE. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. J Immunol 1982; 128:2374-6.
4. Szalai AJ, Briles DE, Volanakis JE. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol 1995; 155:2557-63.
5. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34:141-212.
6. Carlucci F, Cook HT, Garg A, Pepys MB, Botto M. Lack of effect of a single injection of human C-reactive protein on murine lupus or nephrotoxic nephritis. Arthritis Rheum 2010; 62:245-9.
7. de Beer FC, Pepys MB. Isolation of human C-reactive protein and serum amyloid P component. J Immunol Methods 1982; 50:17-31.
8. Molden DP, Nakamura RM, Tan EM. Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity. Am J Clin Pathol 1984; 82:57-66.
9. Noursadeghi M, Bickerstaff MCM, Gallimore JR, Herbert J, Cohen J, Pepys MB. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci USA 2000; 97:14584-9.
10. Teupser D, Weber O, Rao TN, Sass K, Thiery J, Fehling HJ. No reduction of atherosclerosis in C-reactive protein (CRP) -deficient mice. J Biol Chem 2011; 286:6272-9.
11. Pepys MB, Baltz M, Gomer K, Davies AJS, Doenhoff M. Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 1979; 278:259-61.
12. Pepys MB, Lanham JG, de BF. C-reactive protein in systemic lupus erythematosus. In: Hughes GRV, ed. Clinics in the Rheumatic Diseases, 1st edn. Eastbourne: W.B. Saunders Co Ltd, 1982: 91-103.
13. Pepys MB, Butler PJG. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem Biophys Res Commun 1987; 148:308-13.
14. Butler PJG, Tennent GA, Pepys MB. Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J Exp Med 1990; 172:13-8.
15. Hirschfield GM, Herbert J, Kahan MC, Pepys MB. Human C-reactive protein does not protect against acute lipopolysaccharide challenge in mice. J Immunol 2003; 171:6046-51.
16. Sørensen UBS, Agger R, Bennedsen J, Henrichsen J. Phosphorylcholine determinants in six pneumococcal capsular polysaccharides detected by monoclonal antibody. Infect Immun 1984; 43:876-8.
17. Pepys MB, Booth DR, Hutchinson WL, Gallimore JR, Collins PM, Hohenester E. Amyloid P component. A critical review. Amyloid 1997; 4:274-95.
18. Briles DE, Forman C, Hudak S, Claflin JL. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 1982; 156:1177-85.
19. McCullers JA, Tuomanen EI. Molecular pathogenesis of pneumococcal pneumonia. Front Biosci 2001; 6:D877-89.
20. Agrawal A, Suresh MV, Singh SK, Ferguson DA Jr. The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection. Endocr Metab Immune Disord Drug Targets 2008; 8:231-7.
21. Volanakis JE, Wirtz KWA. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature 1979; 281:155-7.
22. de Beer FC, Soutar AK, Baltz ML, Trayner I, Feinstein A, Pepys MB. Low density and very low density lipoproteins are selectively bound by aggregated C-reactive protein. J Exp Med 1982; 156:230-42.
23. Hart SP, Alexander KM, MacCall SM, Dransfield I. C-reactive protein does not opsonize early apoptotic human neutrophils, but binds only membrane-permeable late apoptotic cells and has no effect on their phagocytosis by macrophages. J Inflamm (Lond) 2005; 2:5.
24. Guo WX, Burger AM, Fischer RT, Sieckmann DG, Longo DL, Kenny JJ. Sequence changes at the V-D junction of the VH1 heavy chain of anti-phosphocholine antibodies alter binding to and protection against Streptococcus pneumoniae. Int Immunol 1997; 9:665-77.
25. Mukerji R, Mirza S, Roche AM et al. Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine. J Immunol 2012; 189:5327-35.
26. Harnett W, Harnett MM. Phosphorylcholine: friend or foe of the immune system? Immunol Today 1999; 20:125-9.
27. Roy S, Hill AV, Knox K, Griffiths D, Crook D. Research pointers: association of common genetic variant with susceptibility to invasive pneumococcal disease. BMJ 2002; 324:1369.
28. Eklund C, Huttunen R, Syrjänen J, Laine J, Vuento R, Hurme M. Polymorphism of the C-reactive protein gene is associated with mortality in bacteraemia. Scand J Infect Dis 2006; 38:1069-73.
29. Mukamal KJ, Pai JK, O'Meara ES et al. CRP gene variation and risk of community-acquired pneumonia. Respirology 2010; 15:160-4.